Unveiling Patterson (PDCO)'s Value: Is It Really Priced Right? A Comprehensive Guide

Article's Main Image

Amidst a tumultuous market, Patterson Companies Inc (PDCO, Financial) has experienced a significant daily loss of 17.24%, and a 3-month decline of 21.3%. Yet, with an Earnings Per Share (EPS) of $2.19, investors are prompted to question: is Patterson modestly undervalued? This article delves into the valuation analysis of Patterson (PDCO), offering an in-depth perspective on whether the current market price reflects the company's true intrinsic value.

Company Introduction

Patterson Companies Inc is a distinguished player in the dental and animal health markets, operating through two main segments: Patterson Dental, and Patterson Animal Health. With the majority of revenue generated from the United States, the company has cemented its status as a leading distributor and wholesaler of consumable products and equipment. The current stock price of $26.01, juxtaposed with a market cap of $2.10 billion, stands in contrast to the GF Value of $32.32, suggesting a potential undervaluation worth exploring.


Summarize GF Value

The GF Value is a unique metric that encapsulates the intrinsic value of a stock, calculated through a blend of historical trading multiples, adjustments based on past performance, and future business projections. Patterson (PDCO, Financial) is currently pegged as modestly undervalued according to this measure. This undervaluation indicates that the stock could potentially offer a higher long-term return relative to its business growth, positioning it as an attractive option for value investors.


Link: These companies may deliver higher future returns at reduced risk.

Financial Strength

Discerning investors know that a company's financial strength is paramount to mitigate the risk of capital loss. Patterson's cash-to-debt ratio of 0.16 ranks below many of its industry peers. With a financial strength score of 7 out of 10, Patterson's financial foundation is considered fair, yet it's important to monitor this aspect to ensure the company's long-term stability.

Profitability and Growth

Profitability is a critical indicator of a company's health and its potential to deliver returns. Patterson has maintained profitability for 9 out of the past 10 years, with a solid operating margin that outperforms many within the industry. However, growth remains an area for improvement, as evidenced by its average annual revenue growth rate and EBITDA growth rate, which lag behind industry counterparts.


Comparing Return on Invested Capital (ROIC) to the Weighted Average Cost of Capital (WACC) can reveal much about a company's profitability. Patterson's ROIC outstrips its WACC, indicating efficient capital use and value creation for shareholders—a promising sign for investors.


In summary, Patterson (PDCO, Financial) appears modestly undervalued, with fair financial health and profitability. While its growth rates may not be leading the industry, the company's ability to consistently generate profit and its efficient capital allocation suggest a potential for future value appreciation. For a deeper dive into Patterson's financials, interested parties can explore the 30-Year Financials here.

To discover high-quality companies that may deliver above-average returns, take a look at the GuruFocus High Quality Low Capex Screener.

This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.


I/we have no positions in any stocks mentioned, and have no plans to buy any new positions in the stocks mentioned within the next 72 hours. Click for the complete disclosure